Literature DB >> 2692259

Mechanism of hypersensitivity reactions: proposed involvement of reactive metabolites generated by activated leukocytes.

J Uetrecht.   

Abstract

Hypersensitivity drug reactions are a major source of serious adverse drug reactions, yet very little is known about their mechanism. Several drugs are oxidized by activated neutrophils and mononuclear cells to reactive metabolites. Jack Uetrecht explains that the pattern of hypersensitivity reactions associated with these drugs - drug-induced lupus, agranulocytosis, and generalized hypersensitivity reactions - fits a mechanism in which leukocyte-generated reactive metabolites initiate the hypersensitivity reaction. Because activation of the leukocyte is necessary for reactive metabolite formation, one risk factor for a drug hypersensitivity reaction may be an infection or other inflammatory condition.

Entities:  

Mesh:

Year:  1989        PMID: 2692259     DOI: 10.1016/S0165-6147(89)80012-4

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  10 in total

Review 1.  Inborn 'errors' of drug metabolism. Pharmacokinetic and clinical implications.

Authors:  M S Lennard; G T Tucker; H F Woods
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

Review 2.  [Detection and evaluation of adverse drug reactions].

Authors:  P A Thürmann; K Schmitt
Journal:  Med Klin (Munich)       Date:  1998-11-15

3.  Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus.

Authors:  A Kretz-Rommel; S R Duncan; R L Rubin
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

Review 4.  Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.

Authors:  M Pirmohamed; S Madden; B K Park
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

Review 5.  Genetically determined adverse drug reactions involving metabolism.

Authors:  M S Lennard
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

6.  Mechanism of clozapine-induced agranulocytosis : current status of research and implications for drug development.

Authors:  M Pirmohamed; K Park
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

Review 7.  Idiosyncratic drug-induced haematological abnormalities. Incidence, pathogenesis, management and avoidance.

Authors:  W N Patton; S B Duffull
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

Review 8.  Possible role of free radical formation in drug-induced agranulocytosis.

Authors:  R P Mason; V Fischer
Journal:  Drug Saf       Date:  1992       Impact factor: 5.606

Review 9.  The dental amalgam issue. A review.

Authors:  M Hanson; J Pleva
Journal:  Experientia       Date:  1991-01-15

Review 10.  Peroxidative metabolism of carcinogenic N-arylhydroxamic acids: implications for tumorigenesis.

Authors:  D Malejka-Giganti; C L Ritter
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.